Loading clinical trials...

Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708 | Clinical Trials | Clareo Health

Active Not RecruitingNCT05317637

Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708

Osteogenesis imperfecta (OI) is a group of congenital and heritable bone disorders that currently affects at least 50,000 people in the United States. OI varies in severity from perinatally lethal to ...

Lead sponsor: Baylor College of Medicine•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 3

Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

NCT07366086 · Osteogenesis Imperfecta

RECRUITINGNA

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more

RECRUITINGPhase 4

Effects of Bisphosphonates on OI-Related Hearing Loss

NCT04152551 · Osteogenesis Imperfecta

Active Not RecruitingPhase 1/2

Boost Brittle Bones Before Birth

NCT03706482 · Osteogenesis Imperfecta

COMPLETED

Evaluation and Treatment of Patients With Connective Tissue Disease

NCT00076830 · Connective Tissue Disorders, Osteogenesis Imperfecta, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 2, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment18

Start dateAug 2022

Last updatedMar 2, 2026

Condition

Osteogenesis Imperfecta

Locations shown

University of California Los Angeles

Los Angeles, California

Kennedy Krieger Institute / Hugo W. Moser Research Institute

Baltimore, Maryland

Hospital for Special Surgery

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions